AZD-3199
AZD-3199 is an ultra-long-acting beta2 agonist with potential activity against asthma and chronic obstructive pulmonary disease[1].
Product Specifications
CAS Number
925243-19-2
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/azd-3199.html
Smiles
O=C1SC2=C(N1)C(O)=CC=C2CCNCCN(CCN(CC)CC)C(CCOCCC3=CC=CC4=C3C=CC=C4)=O
Molecular Formula
C32H42N4O4S
Molecular Weight
578.77
References & Citations
[1]Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
O2970-80B-ML490 100 µL
OASIS, CT (Cyclic AMP-responsive Element-binding Protein 3-like Protein 1, cAMP-responsive Element-binding Protein 3-like Protein 1, Old Astrocyte Specifically-induced Substance, Processed Cyclic AMP-responsive Element-binding Protein 3-like Protein 1, CREB3L1, PSEC0238) (MaxLight 490) discontinued
Sign In for Pricing
View Details GTR15150288 1 Vial
Lentiviral human LIPG shRNA (UAS) - Lentiviral human LIPG shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details GTR15128528 1 Vial
Lentiviral mouse Ctsf shRNA (UAS) - Lentiviral mouseCtsf shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 